ETF Edge cover image

ETF Edge

Taking on the “tokenization” of assets 9/23/24

Sep 23, 2024
Explore the groundbreaking concept of asset tokenization and its potential to revolutionize the ETF industry. Discover how traditional assets are being transformed into digital tokens, improving efficiency and transparency. Discuss the rise of ETFs driven by younger investors amid shifting economic conditions and evolving fixed income preferences. Gain insights from the Future Proof Conference about marketing strategies for RIAs and navigate the economic landscape influenced by the Federal Reserve and upcoming elections.
27:18

Podcast summary created with Snipd AI

Quick takeaways

  • The tokenization of financial assets promises to revolutionize investment transactions by enhancing accessibility and market efficiency through blockchain technology.
  • Despite potential disruptions, the ETF market continues to thrive, driven by strong demand and a shift towards flexibility and cost-effectiveness among younger investors.

Deep dives

Understanding Erleada for Prostate Cancer

Erleada, or Apalutamide, is a prescription medication designed to treat prostate cancer that has metastasized and still responds to treatments that reduce testosterone levels. This medication facilitates the possibility of patients attending significant life events, such as sports games with family, despite their health challenges. However, it is critical to recognize that Erleada may lead to serious side effects, including heart disease, stroke, severe skin reactions, falls, fractures, and seizures. Patients should be aware of the potential risks and consult with their healthcare provider to evaluate if Erleada is suitable for their treatment plan.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner